SCHEMBL4775260

SCHEMBL4775260

Cn1c(C(=O)Nc2ccc3c(c2)CCN(C2CCC2)CC3)c(OC(=O)C(F)(F)F)c2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 11/20 0.40
NPY5R Q15761 1/20 0.39
RAB9A P51151 3/20 0.38
HRH1 P35367 1/20 0.37
POLB P06746 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
TP53 P04637 3/20 0.35
NPC1 O15118 2/20 0.35
NFKB1 P19838 2/20 0.35
HTT P42858 2/20 0.35
NFKB2 Q00653 2/20 0.35
RELA Q04206 2/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4767924 0.82 TMPRSS2 (0.43) HRH3RAB9ASMN1; SMN2TP53NPC1
SCHEMBL4772072 0.80 HRH3 (0.39) HRH3RAB9ASMN1; SMN2NPC1NFKB1
SCHEMBL4775095 0.78 HRH3 (0.41) HRH3RAB9AHRH1SMN1; SMN2TP53
SCHEMBL4770767 0.78 HRH3 (0.42) HRH3HRH1
SCHEMBL4771970 0.77 HRH3 (0.40) HRH3RAB9AHRH1SMN1; SMN2TP53
SCHEMBL4767630 0.77 HRH3 (0.42) HRH3RAB9AHRH1POLBNPC1
Trifluoroacetic Acid SCHEMBL4775257 0.76 ROCK2 (0.44) HRH3RAB9ASMN1; SMN2TP53NPC1
SCHEMBL4769825 0.74 HRH3 (0.41) HRH3HRH1
SCHEMBL4771567 0.74 ROCK2 (0.46) HRH3RAB9ASMN1; SMN2TP53NPC1
Trifluoroacetic Acid SCHEMBL4774158 0.73 TMPRSS2 (0.55) RAB9ASMN1; SMN2TP53NPC1NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP claimed
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists GLAXO GROUP LIMITED (GB) 2007-03-15 US claimed
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists HRH3, HRH4, HRH1 HRH3 1/4885NPY5R 754/4885RAB9A 2307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.